Augenchirurg

Publikationen

 1. Twelve months of follow-up after intravitreal injection of ranibizumab for the treatment of idiopathic parafoveal telangiectasia. Rouvas A,Malamos P, Douvali M, Ntouraki A, Markomichelakis NN Clin Ophthalmol. 2013;7:1357-62.

2. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Rouvas A, Petrou  P, Douvali M, Ntouraki A, Vergados I, Georgalas I, Markomichelakis N Retina 2011 May;31(5):871-9.

3.Angiographic and OCT features of retinal angiomatous proliferation.
Rouvas A, Papakostas TD, Ntouraki A, Douvali M, Vergados I, Ladas I Eye (Lond) 2010 Νοv;24(11):1633-42.

4.Photodynamic therapy, ranibizumab and ranibizumab with photodynamic
therapy for the treatment of polypoidal choroidal vasculopathy. Retina 2011 Mar;31(3):464-74.

5. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion induced macular edema: nine months results of a prospective study.Rouvas A, Petrou P, Ntouraki A, Douvali M, Ladas I, Vergados I. Retina 2010 Jun;30(6):893-902.